To counteract the chemoresistance of BC cells and elucidate the role of the eIF4F complex, the therapeutic and sensitizing effects of several molecules were evaluated under a low dose of Dox (100 nM) to avoid the side effects associated with high Dox doses [61], and proposing a potential sensitizing effect of candidate molecules. Here, EIF4E is linked to breast cancer.